currently lamictal undergoing phase iii trials add treatment schizophrenia recent review say research done point lamotrigine add treatment found five relevant trials total usable data service outcomes general functioning behaviour engagement services satisfaction treatment economic outcomes overall reporting data poor data able use suggested equal proportions people allocated lamotrigine placebo global response rct rr ci significant difference groups proportions people whose mental state improve rct rr ci however significant reduction panss total scores rct wmd ci p positive symptom sub scale scores rcts wmd ci negative symptom sub scale scores rcts wmd ci cognitive measures showed differences rcts rr attaining bacs composite score ci panss shows change good hand usable data number important variables brings issue clinically relevant relationship panss scores real life patient functioning i claiming answer panss scores changing yet mental state however measured also improving going question important nothing single measure indicating improvement mean drug really benefits patients alan kazdin discussed point much brilliantly i could article american psychologist recently made particular concern me fact usable data reported across five trials variety aspects patient functioning lack curiosity part investigators data suppressed i dug deeply one question worth thinking